Changes in pathogen spectrum and antimicrobial resistance development in the time‐course of acute necrotizing pancreatitis

This is the authors' abstract. We don't add key points for this paper.

Antimicrobial treatment of infected pancreatic necrosis becomes more challenging over time, owing to a change in spectrum favoring difficult-to-treat pathogens and an increase in multi-resistant bacteria associated with worse clinical outcomes (World Health Organization trial registration number: DRKS00014785).